Effectiveness of the Herreros Urination Stimulation Technique Versus Bladder Catheterization for Urine Sample Collection in Infants Under 6 Months
Effectiveness of the Herreros Urination Stimulation Technique Versus Bladder Catheterization for Urine Sample Collection in Infants Under 6 Months: A Randomized Clinical Trial Protocol
Urinary tract infections are common in infants, but obtaining a reliable urine sample from babies younger than 6 months can be challenging. Bladder catheterization is a commonly used method for collecting urine, although it is an invasive procedure that may cause discomfort.
This randomized, controlled, open-label clinical trial will compare two methods of urine collection in infants younger than 6 months of age who are suspected of having a urinary tract infection and require a urine test. The study will be conducted at Toledo University Hospital in Spain.
Infants will be randomly assigned to one of two groups. The intervention group will undergo the Herreros technique, a non-invasive method that uses gentle tapping over the lower abdomen and circular massage of the lower back to stimulate spontaneous urination. The control group will undergo intermittent bladder catheterization to collect a urine sample.
The main objective is to compare the success of the two methods in obtaining a urine sample. Secondary objectives include comparing the time required to collect urine, sample contamination rates, pain or discomfort experienced by the infants, complications, costs, and parents' or legal guardians' satisfaction with the procedure.
The study aims to provide evidence on the effectiveness, safety, and cost-effectiveness of the Herreros technique compared with bladder catheterization in infants younger than 6 months.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Urinary tract infection (UTI) is a common bacterial infection in childhood. Obtaining reliable urine samples from infants who are not toilet-trained can be challenging. Bladder catheterization is an established method for urine collection, although it is invasive and may cause pain or discomfort. The Herreros urination stimulation technique is a non-invasive alternative based on physical stimulation of spontaneous urination.
This randomized, controlled, open-label clinical trial will be conducted at Toledo University Hospital, Castilla-La Mancha, Spain. The study will compare the Herreros urination stimulation technique with intermittent bladder catheterization for urine collection in infants with suspected UTI.
A minimum of 60 participants is planned, with 30 participants allocated to each study group. Sample size estimation was performed using the GRANMO program, considering expected urine collection success rates of 86% and 100% in the intervention and control groups, respectively, with a two-sided alpha level of 0.05 and statistical power greater than 80%.
Participants will be randomly assigned in a 1:1 ratio using a computer-generated randomization sequence managed by an independent unit coordinator. Due to the nature of the procedures, blinding of healthcare professionals performing the interventions will not be possible. However, laboratory personnel responsible for urine culture analysis and sample contamination assessment will be blinded to group allocation.
Intervention procedures
In the intervention group, urine collection will be attempted using the Herreros technique. The procedure involves feeding the infant approximately 20-30 minutes before the intervention, cleaning the genital area, and alternating gentle suprapubic tapping with circular massage of the lumbar paravertebral region using the thumbs. These maneuvers will be performed for a maximum of five minutes or until spontaneous urination occurs. A midstream urine sample will then be collected in a sterile container.
Non-pharmacological analgesia, including non-nutritive sucking or 2% sucrose solution, may be used in accordance with the study protocol. If urine collection is unsuccessful within five minutes, bladder catheterization will be performed to obtain the required sample, and this circumstance will be documented.
In the control group, urine samples will be obtained through intermittent bladder catheterization performed by qualified healthcare professionals in accordance with the hospital's standard clinical procedures. The time required to complete the procedure will be recorded using a stopwatch.
Data collection and statistical analysis
Study data will be recorded using a standardized data collection form. Statistical analyses will be performed using IBM SPSS Statistics. Categorical data will be expressed as frequencies and percentages, while quantitative data will be summarized using means and standard deviations or appropriate alternative descriptive statistics.
Between-group comparisons will be performed using the chi-square test or Fisher's exact test for categorical variables and Student's t-test or Mann-Whitney U test for quantitative variables, depending on data distribution. Pearson or Spearman correlation analyses and multiple logistic regression will be used, where appropriate, to explore associations between relevant study variables.
Safety monitoring and ethical considerations
Participants will be monitored by the healthcare professionals performing the urine collection procedures. Any complications or adverse events potentially related to either technique will be documented, and appropriate clinical care will be provided. Serious adverse events will be reported to the unit coordinator and principal investigator within 24 hours.
The study will commence only after approval by the relevant Research Ethics Committee and authorization from the participating hospital services. Written informed consent will be obtained from parents or legal guardians before participation. All study data will be handled confidentially in accordance with applicable Spanish data protection legislation and ethical principles governing biomedical research.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: FRANCISCO JAVIER GÓMEZ MANZANO Principal Investigator, BSc
- Phone Number: +34653782821
- Email: javier.gomezmanzano@uclm.es
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Infants of both sexes under 6 months of age (up to 180 days).
- Infants requiring a urine sample collection for the diagnosis of a suspected urinary tract infection (UTI) prescribed by a physician in the neonatology, pediatrics, or pediatric emergency department.
- Parents or legal guardians willing and able to sign the informed consent form.
Exclusion Criteria:
- Infants with prior antibiotic treatment.
- Infants with a diagnosis of urological or gynecological congenital malformations, severe phimosis, tight labial adhesions in females, genital infection, or complex genital abnormalities.
- Infants presenting with any skin lesion (such as wounds, burns, trauma, etc.) that could contraindicate or prevent the performance of the Herreros technique and/or urinary catheterization.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Herreros Bladder Stimulation Group
Infants undergo the non-invasive bladder stimulation technique described by Herreros et al., combining feeding with gentle suprapubic taps and lumbar paravertebral massage to induce spontaneous midstream urine collection. |
Infants receive the non-invasive bladder stimulation technique described by Herreros et al. This involves a feeding (breast milk or formula) 20 to 30 minutes prior to the procedure, followed by a maximum of 5 minutes of alternating cycles of gentle suprapubic tapping (using fingertips) and lumbar paravertebral massage (using circular thumb movements). Non-pharmacological analgesia (such as a pacifier or 2% sucrose) is administered during the procedure.
Other Names:
|
|
Active Comparator: Urinary Catheterization Group
Infants undergo intermittent urinary catheterization as the reference standard procedure for obtaining a sterile urine sample. |
Infants undergo intermittent urinary catheterization as the reference standard procedure. After proper perineal cleansing and the application of sterile lubricant, a pediatric urinary catheter (size 6-8 Fr) is gently inserted through the urethra into the bladder to obtain a sterile urine sample. Non-pharmacological analgesia (such as a pacifier or 2% sucrose) is provided during the procedure.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Successful urine sample collection rate
Time Frame: Within 5 minutes (300 seconds) from the start of the procedure
|
Percentage of infants in each group in whom a sufficient urine sample for urinalysis and urocultivo is successfully obtained within 5 minutes after the start of the procedure. |
Within 5 minutes (300 seconds) from the start of the procedure
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to urine collection
Time Frame: From the start of the urine collection procedure (hand hygiene and glove placement) until a urine sample sufficient for culture is obtained, assessed up to 5 minutes (300 seconds).
|
The total time elapsed (in seconds) from the start of the procedure until the successful collection of the urine sample. |
From the start of the urine collection procedure (hand hygiene and glove placement) until a urine sample sufficient for culture is obtained, assessed up to 5 minutes (300 seconds).
|
|
Urine sample contamination rate
Time Frame: From urine collection until the final urine culture report, assessed up to 72 hours
|
Percentage of collected urine samples classified as contaminated based on urocultive criteria (such as growth of two or more microorganisms, presence of non-uropathogens, or leukocyturia). |
From urine collection until the final urine culture report, assessed up to 72 hours
|
|
Parental satisfaction score
Time Frame: Immediately after the procedure, before discharge
|
Evaluation of parents' or legal guardians' satisfaction with the procedure, measured using an ad-hoc survey on a scale. PARENT/GUARDIAN OPINION AND SATISFACTION QUESTIONNAIRE FOR THE INFANT. The minimum score is 0, indicating the worst possible outcome, in which parents/legal guardians are not at all satisfied with the procedure performed on their infant or with the time required to obtain the urine sample. The maximum score is 10, indicating that parents/legal guardians are very satisfied with both the procedure performed and the time required to obtain the urine sample. |
Immediately after the procedure, before discharge
|
|
Procedure costs
Time Frame: During the urine collection procedure (including rescue catheterization, if needed)
|
Direct economic cost of each procedure based on material resources utilized and healthcare personnel time required per successful sample obtained. |
During the urine collection procedure (including rescue catheterization, if needed)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Male Urogenital Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Infections
- Urinary Tract Infections
- Investigative Techniques
- Therapeutics
- Diagnostic Techniques and Procedures
- Diagnosis
- Catheterization
- Diagnostic Techniques, Urological
- Urinary Catheterization
Other Study ID Numbers
Other Study ID Numbers
- 2295
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.